CN107198078A - Stage of icterus small peptide growing nutrient element and technique manufacturing method - Google Patents
Stage of icterus small peptide growing nutrient element and technique manufacturing method Download PDFInfo
- Publication number
- CN107198078A CN107198078A CN201710414990.7A CN201710414990A CN107198078A CN 107198078 A CN107198078 A CN 107198078A CN 201710414990 A CN201710414990 A CN 201710414990A CN 107198078 A CN107198078 A CN 107198078A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- somebody
- icterus
- oiling
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010023126 Jaundice Diseases 0.000 title claims abstract description 90
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 65
- 241001662043 Icterus Species 0.000 title claims abstract description 55
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 49
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 29
- 239000000843 powder Substances 0.000 claims abstract description 145
- 235000016709 nutrition Nutrition 0.000 claims abstract description 91
- 239000005862 Whey Substances 0.000 claims abstract description 90
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 90
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 90
- 230000035764 nutrition Effects 0.000 claims abstract description 82
- 102100026189 Beta-galactosidase Human genes 0.000 claims abstract description 37
- 108010059881 Lactase Proteins 0.000 claims abstract description 37
- 108010005774 beta-Galactosidase Proteins 0.000 claims abstract description 37
- 229940116108 lactase Drugs 0.000 claims abstract description 37
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 33
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 33
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 33
- 235000021241 α-lactalbumin Nutrition 0.000 claims abstract description 33
- 239000008103 glucose Substances 0.000 claims abstract description 32
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 28
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 28
- 230000007062 hydrolysis Effects 0.000 claims abstract description 28
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 28
- 241000195493 Cryptophyta Species 0.000 claims abstract description 24
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 96
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 78
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 78
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 78
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 72
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 48
- 229960000304 folic acid Drugs 0.000 claims description 48
- 235000019152 folic acid Nutrition 0.000 claims description 48
- 239000011724 folic acid Substances 0.000 claims description 48
- 239000011715 vitamin B12 Substances 0.000 claims description 47
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 40
- 239000011575 calcium Substances 0.000 claims description 40
- 229910052791 calcium Inorganic materials 0.000 claims description 40
- 239000011716 vitamin B2 Substances 0.000 claims description 40
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 39
- 229930003268 Vitamin C Natural products 0.000 claims description 39
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 39
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 39
- 235000001968 nicotinic acid Nutrition 0.000 claims description 39
- 229960003512 nicotinic acid Drugs 0.000 claims description 39
- 239000011664 nicotinic acid Substances 0.000 claims description 39
- 239000000047 product Substances 0.000 claims description 39
- 239000011691 vitamin B1 Substances 0.000 claims description 39
- 235000019154 vitamin C Nutrition 0.000 claims description 39
- 239000011718 vitamin C Substances 0.000 claims description 39
- 239000011670 zinc gluconate Substances 0.000 claims description 39
- 235000011478 zinc gluconate Nutrition 0.000 claims description 39
- 229960000306 zinc gluconate Drugs 0.000 claims description 39
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 38
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 38
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 38
- 235000019155 vitamin A Nutrition 0.000 claims description 38
- 239000011719 vitamin A Substances 0.000 claims description 38
- 239000011726 vitamin B6 Substances 0.000 claims description 38
- 229940045997 vitamin a Drugs 0.000 claims description 38
- 239000001506 calcium phosphate Substances 0.000 claims description 37
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 37
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 37
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 37
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 37
- 229930003427 Vitamin E Natural products 0.000 claims description 36
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 36
- 235000019165 vitamin E Nutrition 0.000 claims description 36
- 239000011709 vitamin E Substances 0.000 claims description 36
- 229940046009 vitamin E Drugs 0.000 claims description 36
- 239000011706 ferric diphosphate Substances 0.000 claims description 32
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 32
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 32
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 32
- 239000011647 vitamin D3 Substances 0.000 claims description 32
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 29
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 28
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 27
- 238000012545 processing Methods 0.000 claims description 27
- 239000002994 raw material Substances 0.000 claims description 26
- 229960003563 calcium carbonate Drugs 0.000 claims description 23
- 235000010216 calcium carbonate Nutrition 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 22
- 239000003795 chemical substances by application Substances 0.000 claims description 21
- 238000010790 dilution Methods 0.000 claims description 21
- 239000012895 dilution Substances 0.000 claims description 21
- 150000004667 medium chain fatty acids Chemical class 0.000 claims description 20
- 239000000178 monomer Substances 0.000 claims description 20
- 238000007873 sieving Methods 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 17
- 229940088594 vitamin Drugs 0.000 claims description 16
- 229930003231 vitamin Natural products 0.000 claims description 16
- 235000013343 vitamin Nutrition 0.000 claims description 16
- 239000011782 vitamin Substances 0.000 claims description 16
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 16
- 240000004760 Pimpinella anisum Species 0.000 claims description 14
- 235000012550 Pimpinella anisum Nutrition 0.000 claims description 14
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 11
- 238000003672 processing method Methods 0.000 claims description 9
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 6
- 239000003531 protein hydrolysate Substances 0.000 claims description 6
- 235000021050 feed intake Nutrition 0.000 claims description 5
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- 229930003270 Vitamin B Natural products 0.000 claims 1
- FYHXNYLLNIKZMR-UHFFFAOYSA-N calcium;carbonic acid Chemical compound [Ca].OC(O)=O FYHXNYLLNIKZMR-UHFFFAOYSA-N 0.000 claims 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 229960003284 iron Drugs 0.000 claims 1
- 229940005657 pyrophosphoric acid Drugs 0.000 claims 1
- 235000019156 vitamin B Nutrition 0.000 claims 1
- 239000011720 vitamin B Substances 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 6
- 238000011161 development Methods 0.000 abstract description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract 1
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 75
- 235000013305 food Nutrition 0.000 description 18
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 17
- 229910052500 inorganic mineral Inorganic materials 0.000 description 15
- 235000010755 mineral Nutrition 0.000 description 15
- 239000011707 mineral Substances 0.000 description 15
- 206010016946 Food allergy Diseases 0.000 description 14
- 102000014171 Milk Proteins Human genes 0.000 description 14
- 108010011756 Milk Proteins Proteins 0.000 description 14
- BPYKTIZUTYGOLE-UHFFFAOYSA-N billirubin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(C=C3C(=C(C=C)C(=O)N3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-UHFFFAOYSA-N 0.000 description 14
- 235000021239 milk protein Nutrition 0.000 description 14
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 13
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 13
- 229940097043 glucuronic acid Drugs 0.000 description 13
- 206010023138 Jaundice neonatal Diseases 0.000 description 12
- 201000010538 Lactose Intolerance Diseases 0.000 description 10
- 210000000481 breast Anatomy 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 238000001727 in vivo Methods 0.000 description 8
- 230000002028 premature Effects 0.000 description 8
- 239000005955 Ferric phosphate Substances 0.000 description 7
- 230000008499 blood brain barrier function Effects 0.000 description 7
- 210000001218 blood-brain barrier Anatomy 0.000 description 7
- 230000003197 catalytic effect Effects 0.000 description 7
- 210000000170 cell membrane Anatomy 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 229940032958 ferric phosphate Drugs 0.000 description 7
- 210000000232 gallbladder Anatomy 0.000 description 7
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 7
- 229910000399 iron(III) phosphate Inorganic materials 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 102000016354 Glucuronosyltransferase Human genes 0.000 description 6
- 108010092364 Glucuronosyltransferase Proteins 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000004519 grease Substances 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000027219 Deficiency disease Diseases 0.000 description 4
- 208000002720 Malnutrition Diseases 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 238000010612 desalination reaction Methods 0.000 description 4
- 235000020256 human milk Nutrition 0.000 description 4
- 210000004251 human milk Anatomy 0.000 description 4
- 238000005286 illumination Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 235000018343 nutrient deficiency Nutrition 0.000 description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 241000219095 Vitis Species 0.000 description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 description 3
- 235000014787 Vitis vinifera Nutrition 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000014103 egg white Nutrition 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 210000003786 sclera Anatomy 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- MUCZHBLJLSDCSD-UHFFFAOYSA-N diisopropyl fluorophosphate Chemical compound CC(C)OP(F)(=O)OC(C)C MUCZHBLJLSDCSD-UHFFFAOYSA-N 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010008796 Chromaturia Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000036364 Normal newborn Diseases 0.000 description 1
- 206010058117 Ocular icterus Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 208000027119 bilirubin metabolic disease Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000036796 hyperbilirubinemia Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pediatric Medicine (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to stage of icterus small peptide growing nutrient element and technique manufacturing method, the mass percent that wherein each component accounts for product is：Oiling desalted whey is with feed powder 59.85% 87.27%, depth hydrolysis' albumen 1.40% 7.30%, alpha-lactalbumin 1.00% 5.70%, edible glucose 6.15% 18.37%, nutrition fortifier 1.07% 2.60%, FOS 1.58% 2.63%, galactooligosaccharide 1.30% 2.20%, lactase 0.05% 0.25%, algae oil DHA powder 0.08% 0.40%, ARA powder 0.10% 0.70%.Beneficial effects of the present invention：It is oral by reconstituting, reduce the pain that neonate brings by jaundice.Add nutrition fortifier and ensure that the neonatal development stage obtains comprehensively rational nutrition, the normal need of physiology and life is met, to maintain and improve the neonatal general level of the health.
Description
Technical field
The invention belongs to protein solid beverage field, more particularly to a kind of is icterus neonatorum and hyperbilirubinemia crowd
The stage of icterus small peptide growing nutrient element and technique manufacturing method of nutritional support are provided.
Background technology
Jaundice is common sympton and sign, and it is due to bilirubin metabolism obstacle and causes bilirubin concentration in serum
Caused by rise.Clinical signs are that sclera, mucous membrane, skin and its hetero-organization are dyed to yellow.Because sclera contains more elasticity
Scleroprotein, has stronger affinity with bilirubin, thus Patients with Jaundice icteric sclera often prior to mucous membrane, skin and be noticeable first.
When serum total bilirubin does not see jaundice in 17.1~34.2 μm of ol/L, and naked eyes, claim jaundice occult or subclinical jaundice；When
When bloodstain total bilirubin concentration is more than 34.2 μm of ol/L, jaundice, also referred to as clinical jaundice can be clinically found.Medically not
The jaundice of full moon (in birth 28 days) baby, referred to as icterus neonatorum, there is point of physiological and pathologic.General symptom is generally
Spirit is poor, and yellowing of the skin is shinny, poor, brown urine of sucking the breast.Different type absurdity and corresponding symptom and feature.
After normal neonate's life from 3 days, sclera, mucous membrane, skin and its hetero-organization can start little by little to be dyed to yellow,
In the trend aggravated gradually, about to after 7 days, gradually disappear, almost basic by the 10th day to disappear, this is neonate's physiological
The process of jaundice.Jaundice occurs in about 60% term infant and 80% premature, and the original of physiologic jaundice occurs for neonate
Because being mainly：In intrauterine, the red blood cell of fetus is much higher far beyond the red blood cell of adult, it is raw after neonatal erythrocyte number by
Decrescence few, to the erythrocyte number transition of adult, then excessive red blood cell is destroyed, discharges bilirubin, and neonate
Shunted bilirubin source is more, and liver function is still immature, and liver excretion bilirubin function is poor, and the function that excretion combines bilirubin is poor.This
Outside, normal flora is not yet set up in enteron aisle when neonate is just born, it is impossible to which the bilirubin for entering enteron aisle is converted into UBG excrement
Courage is former, neonate is occurred jaundice.Typically, during physiologic jaundice, bilirubin will not be too high, more in 205 μm of below ol/L, to child
Son there will not be big influence, but if can not timely and effectively control and prevention is likely to deteriorate that to turn into pathologic yellow
Subcutaneous ulcer.But sometimes due to pregnant drug, has such as used the medicine of sulfamido, there is the danger for aggravating jaundice.Individual other icterus neonatorum
Heavier, more than 205 μm ol/L, doctor can irradiate blue light to child, or also need plus albumin intravenous injection, to subtract subicteric journey
Degree.
When carrying out blue light illumination, the bilirubin in skin shallow-layer is absorbed after light, and structure just changes, by original
Fat-soluble to become water-soluble, making bilirubin, metabolic pathway changes in vivo, can be excreted out from bile, urine, so that
Mitigate icterus neonatorum.In the visible spectrum, wavelength is most strong in 420~460mm effect of the light to bilirubin, and blue light ripple
A length of 425-480mm, therefore as the best light source for the treatment of icterus neonatorum.Blue-light treatment does not have complication substantially, and its is common
Adverse reaction have heating, diarrhoea, fash etc..But it is noted that：, must for heavier jaundice, it is impossible to individually using blue-light treatment
Must complex treatment, such as combination medicine, nutrient.
The content of the invention
For the above mentioned problem to be solved, the present invention provides stage of icterus small peptide growing nutrient element and technique manufacturing method.
Technical scheme：Stage of icterus small peptide growing nutrient element, including oiling desalted whey match somebody with somebody feed powder, table grapes
Sugar, α-lactalbumin, depth hydrolysis' albumen, nutrition fortifier, FOS, galactooligosaccharide, lactase, algae oil DHA powder,
ARA powder.
Further, each component accounts for the mass percent of product：Oiling desalted whey matches somebody with somebody feed powder 59.85%-87.27%,
Depth hydrolysis albumen 1.40%-7.30%, α-lactalbumin 1.00%-5.70%, edible glucose 6.15%-18.37%, battalion
Support hardening agent 1.07%-2.60%, FOS 1.58%-2.63%, galactooligosaccharide 1.30%-2.20%, lactase
0.05%-0.25%, algae oil DHA powder 0.08%-0.40%, ARA powder 0.10%-0.70%.
Further, oiling desalted whey, which is matched somebody with somebody, includes medium chain fatty acid MCT in feed powder.
Further, nutrition fortifier includes calcium carbonate, tricalcium phosphate, ferric pyrophosphate, zinc gluconate, vitamin A, dimension
Raw element D3, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, D-VB5 calcium, vitamin C.
Further, the medium chain fatty acid MCT that oiling desalted whey is matched somebody with somebody in feed powder accounts for the 23.94%- of this product
34.91%.
Further, each component nutrient accounts for the mass percent of total nutrition fortifier：Calcium carbonate 15.96%-
21.04%th, tricalcium phosphate 29.95%-51.09%, ferric pyrophosphate 9.85%-13.76%, zinc gluconate 2.23%-
6.79%th, vitamin A 0.31%-0.71%, vitamin D30.05%-0.09%, vitamin E 2.34%-2.77%, dimension life
Plain B10.07%-0.47%, vitamin B21.34%-1.81%, vitamin B60.04%-0.44%, vitamin B12
0.07%-0.47%, nicotinic acid 1.49%-1.91%, folic acid 0.06%-0.11%, D-VB5 calcium 0.18%-0.58%, dimension life
Plain C 14.92%-19.10%.
A kind of process for manufacturing stage of icterus small peptide growing nutrient element, it is characterised in that comprise the following steps：
Step one：Determine to need the nutrition fortifier pre-processed in advance to have tricalcium phosphate, calcium carbonate, vitamin C, Jiao first
Ferric phosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, vitamin B2, vitamin B6, dimension
Raw element D3, folic acid, vitamin B12, processing method is as follows：
(1) vitamin B2, folic acid, vitamin B12Gradient dilution is needed to handle, according to the dilution ratio of different material, accurately
Calculate raw material and oiling desalted whey matches somebody with somebody the consumption of feed powder, carry out after gradient mixing, sieve respectively, then enter mixing tank respectively respectively
It is well mixed, tank sieving, standard compliant raw material after being handled are gone out respectively；
(2) tricalcium phosphate, calcium carbonate, vitamin C, ferric pyrophosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A,
D-VB5 calcium, vitamin B1, vitamin B6, vitamin D3Need first to sieve, extracting screen underflow, then oversize is again by crushing, grinding
Honed sieve, obtains the standard compliant raw material of institute.
Step 2：Hardening agent component is supported into according to prescription quality percentage precise by each processing rear batallion, specifically：
1) tricalcium phosphate, calcium carbonate, ferric pyrophosphate, zinc gluconate are added into mixing tank successively in order first to be filled
Divide mixing sieving, obtain mineral-supplemented dose of bag；
2) and then in order successively by vitamin C, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, dimension life
Plain B2, vitamin B6, vitamin D3, folic acid, vitamin B12Add mixing tank to carry out being sufficiently mixed sieving, obtain vitamin enrichment
Agent bag；
Step 3：According to formula each component mass percent precise and by oiling desalted whey with feed powder, edible Portugal
Grape sugar, α-lactalbumin, depth hydrolysis' albumen, FOS, galactooligosaccharide, lactase are thrown into mixing tank successively in order
Material is fully mixed, and sieve to obtain aniseed bag；
Step 4：The mineral-supplemented dose of bag and vitamin enrichment bag that step 2 is mixed put into aniseed bag and filled successively
Divide mixing, sieving produces product.
Further, vitamin B2, folic acid, vitamin B12Gradient dilution processing is needed to specifically refer to：
Vitamin B2Before processing content of monomer 100%, adds auxiliary material oiling desalted whey and matches somebody with somebody feed powder content of monomer 10%；
Folic acid before processing content of monomer 98%, adds auxiliary material oiling desalted whey and matches somebody with somebody feed powder content of monomer 0.1%；
Vitamin B12Before processing content of monomer 98%, adds auxiliary material oiling desalted whey and matches somebody with somebody feed powder content of monomer 10%.
Further, sieving is 60 mesh sieves in the step one；Sieving is 60 mesh sieves in the step 2.
Further, sieving is 40 mesh sieves in the step 3.
Present invention has the advantages that：Formula sets reasonable, and α-lactalbumin can be coupled with unconjugated bilirubin, so as to hinder
Only bilirubin passes through pellicle such as cell membrane, placenta, gall-bladder, blood-brain barrier；Edible monomeric glucose can change into Portugal in vivo
Grape uronic acid, glucuronic acid can combine to form combination under the catalytic action of glucuronyl transferase with unconjugated bilirubin
Bilirubin is external so as to discharge it, and has very great help to the treatment for promoting icterus neonatorum.In addition, depth hydrolysis' albumen is reduced
The possibility of neonate's milk protein allergy, lactase can prevent premature or neonate's lactose intolerance again, help baby to exist
In stage of icterus, while alleviating and shorten the jaundice course of disease, evade milk protein allergy and lactose intolerance problem, body is can ensure that again
The sufficient nutrition for meeting demand of growing is obtained by reconstituting orally, the pain that neonate brings by jaundice is reduced.Addition battalion
Support hardening agent and ensure that the neonatal development stage obtains comprehensively rational nutrition, the normal need of physiology and life is met, to tie up
The neonatal general level of the health is held and improves, the technique manufacturing method of stage of icterus small peptide growing nutrient element is reasonable in design, it is easy to raw
Production, is easy to control.
Brief description of the drawings
Fig. 1 is a kind of process schematic flow sheet for manufacturing stage of icterus small peptide growing nutrient element of the present invention.
Embodiment
A kind of embodiment to the present invention is explained below in conjunction with the accompanying drawings.
The present invention relates to stage of icterus small peptide growing nutrient element and technique manufacturing method.
Stage of icterus small peptide growing nutrient element, including oiling desalted whey match somebody with somebody feed powder, edible glucose, α-lactalbumin, depth
Spend protein hydrolysate, nutrition fortifier, FOS, galactooligosaccharide, lactase, algae oil DHA powder, ARA powder.
α-lactalbumin can be coupled with unconjugated bilirubin, so as to prevent bilirubin from passing through pellicle such as cell membrane, tire
Disk, gall-bladder, blood-brain barrier；Edible monomeric glucose can change into glucuronic acid in vivo, and glucuronic acid is in grape alditol
It can be combined to form under the catalytic action of sour transferase with unconjugated bilirubin with reference to bilirubin so as to discharge it in vitro, to promoting
The treatment of icterus neonatorum has very great help.In addition, depth hydrolysis' albumen reduces the possibility of neonate's milk protein allergy, breast
Carbohydrase can prevent premature or neonate's lactose intolerance again, help baby in stage of icterus, alleviate and shorten the jaundice course of disease
Meanwhile, evade milk protein allergy and lactose intolerance problem, can ensure that body obtains the sufficient battalion for meeting demand of growing again
Support.
Each component accounts for the mass percent of product：Oiling desalted whey matches somebody with somebody feed powder 59.85%-87.27%, depth hydrolysis' egg
White 1.40%-7.30%, α-lactalbumin 1.00%-5.70%, edible glucose 6.15%-18.37%, nutrition fortifier
1.07%-2.60%, FOS 1.58%-2.63%, galactooligosaccharide 1.30%-2.20%, lactase 0.05%-
0.25%, algae oil DHA powder 0.08%-0.40%, ARA powder 0.10%-0.70%.
Oiling desalted whey, which is matched somebody with somebody, includes medium chain fatty acid MCT in feed powder.Oiling desalted whey mainly provides product with feed powder
Fat and protein.Desalted whey powder is to slough the mineral salt in whey powder.For infant, content of mineral substances mistake
Height can increase the kidney burden of baby, therefore whey powder typically can all slough mineral matter.Oiling desalted whey is in this base with feed powder
Increase grease on plinth to meet requirement of the infant to fat.
Nutrition fortifier includes calcium carbonate, tricalcium phosphate, ferric pyrophosphate, zinc gluconate, vitamin A, vitamin D3, dimension
Raw element E, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinic acid, folic acid, D-VB5 calcium, vitamin C.
The medium chain fatty acid MCT that oiling desalted whey is matched somebody with somebody in feed powder accounts for the application stage of icterus small peptide growing nutrient element
23.94%-34.91%.
Each component nutrient accounts for the mass percent of total nutrition fortifier：Calcium carbonate 15.96%-21.04%, tricalcium phosphate
29.95%-51.09%, ferric pyrophosphate 9.85%-13.76%, zinc gluconate 2.23%-6.79%, vitamin A 0.31%-
0.71%th, vitamin D30.05%-0.09%, vitamin E 2.34%-2.77%, vitamin B10.07%-0.47%, dimension
Raw element B21.34%-1.81%, vitamin B60.04%-0.44%, vitamin B120.07%-0.47%, nicotinic acid
1.49%-1.91%, folic acid 0.06%-0.11%, D-VB5 calcium 0.18%-0.58%, vitamin C 14.92%-
19.10%.
Contrast groups data：
Index bilirubin before stage of icterus small peptide nutrient element of the present invention is taken, averagely at 268 micromoles per liters (μm ol/L), to take
Stage of icterus small peptide nutrient element is after three days, and bilirubin declines obvious in average 231 micromoles per liters (μm ol/L), bilirubin.
It is average in 273 micromoles per liters (μm ol/L), clothes that control group 1 takes index bilirubin before " comfortable jaundice nutrient "
With after " comfortable jaundice nutrient " three days, bilirubin still remains high, and with spitting blood and situation about having blood in stool.
Control group 2 is only with blue light, and index bilirubin is average in 259 micromoles per liters (μm ol/L), blue-light treatment before treatment
Bilirubin is average at 224 micromoles per liters (μm ol/L) after three days.
Using stage of icterus small peptide nutrient element auxiliary blue-light treatment, before treatment, index bilirubin is average micro- is rubbed 250 for control group 3
You/liter (μm ol/L), treatment two days later bilirubin in average 206 micromoles per liters (μm ol/L).Show stage of icterus small peptide nutrient element
Auxiliary blue light illumination is coordinated to be relieved jaundice and shorten the jaundice course of disease.
By control group data, show that the stage of icterus small peptide growing nutrient element of the application is used alone, bilirubin declines bright
Aobvious, control group 3 coordinates auxiliary blue light illumination energy using stage of icterus small peptide nutrient element auxiliary blue-light treatment, stage of icterus small peptide nutrient element
It is relieved jaundice and shortens the jaundice course of disease.
Compared with prior art, formula sets reasonable, it is easy to absorb, α-lactalbumin can join with unconjugated bilirubin
Knot, so as to prevent bilirubin from passing through pellicle such as cell membrane, placenta, gall-bladder, blood-brain barrier；Edible monomeric glucose in vivo may be used
Glucuronic acid is changed into, glucuronic acid can be combined under the catalytic action of glucuronyl transferase with unconjugated bilirubin
Formed and combine bilirubin so as to discharge it in vitro, had very great help to the treatment for promoting icterus neonatorum.In addition, depth hydrolysis
Albumen reduces the possibility of neonate's milk protein allergy, and lactase can prevent premature or neonate's lactose intolerance again, helps
Baby is helped in stage of icterus, while alleviating and shorten the jaundice course of disease, evades milk protein allergy and lactose intolerance problem, and energy
Ensure that body obtains the sufficient nutrition for meeting demand of growing by reconstituting orally, reduce the pain that neonate brings by jaundice
It is bitter；Add nutrition fortifier and ensure that the neonatal development stage obtains comprehensively rational nutrition, meet the normal of physiology and life
Need, to maintain and improve the neonatal general level of the health.
A kind of process for manufacturing stage of icterus small peptide growing nutrient element, it is characterised in that comprise the following steps：
Step one：Determine to need the nutrition fortifier pre-processed in advance to have tricalcium phosphate, calcium carbonate, vitamin C, Jiao first
Ferric phosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, vitamin B2, vitamin B6, dimension
Raw element D3, folic acid, vitamin B12, processing method is as follows：
(1) vitamin B2, folic acid, vitamin B12Gradient dilution is needed to handle, according to the dilution ratio of different material, accurately
Calculate raw material and oiling desalted whey matches somebody with somebody the consumption of feed powder, carry out respectively after gradient mixing, sieve 60 mesh sieves respectively, then enters respectively
Mixing tank is well mixed, and tank sieving is gone out respectively, and standard compliant raw material after being handled, specific raw material dilution ratio is shown in Table：
(2) tricalcium phosphate, calcium carbonate, vitamin C, ferric pyrophosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A,
D-VB5 calcium, vitamin B1, vitamin B6, vitamin D3Need to cross 60 mesh sieves respectively, take respective screenings, then will each sieve
Upper thing again by crushing, it is ground sieve respectively, obtain the standard compliant raw material of institute, specifically used equipment is permanent with reference to Tianjin moral
The patent application of Science and Technology Ltd.：The entitled rotary sealing device of rotating shaft of Application No. 200920096540.9, application number
Device is pulverized and mixed for 200920096539.6 entitled one kind.
Step 2：Hardening agent component is supported into according to prescription quality percentage precise by each processing rear batallion, specifically：
Each component nutrient accounts for the mass percent of total nutrition fortifier in formula：Calcium carbonate 15.96%-21.04%,
Tricalcium phosphate 29.95%-51.09%, ferric pyrophosphate 9.85%-13.76%, zinc gluconate 2.23%-6.79%, vitamin
A0.31%-0.71%, vitamin D30.05%-0.09%, vitamin E 2.34%-2.77%, vitamin B10.07%-
0.47%th, vitamin B21.34%-1.81%, vitamin B60.04%-0.44%, vitamin B120.07%-0.47%,
Nicotinic acid 1.49%-1.91%, folic acid 0.06%-0.11%, D-VB5 calcium 0.18%-0.58%, vitamin C 14.92%-
19.10%；
1) tricalcium phosphate, calcium carbonate, ferric pyrophosphate, zinc gluconate are added into mixing tank successively in order first to be filled
Divide mixing sieving, obtain mineral-supplemented dose of bag；
2) and then in order successively by vitamin C, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, dimension life
Plain B2, vitamin B6, vitamin D3, folic acid, vitamin B12Add mixing tank to carry out being sufficiently mixed sieving, obtain vitamin enrichment
Agent bag；
Step 3：According to each component mass percent precise is formulated, specifically：
Each component accounts for the mass percent of product：Oiling desalted whey matches somebody with somebody feed powder 87.27%-59.85%, depth hydrolysis' egg
White 1.40%-7.30%, α-lactalbumin 1.00%-5.70%, edible glucose 6.15%-18.37%, nutrition fortifier
1.07%-2.60%, FOS 1.58%-2.63%, galactooligosaccharide 1.30%-2.20%, lactase 0.05%-
0.25%, algae oil DHA powder 0.08%-0.40%, ARA powder 0.10%-0.70%；
Except nutrition fortifier weighs mixing in step 2, other components process step is as follows：And the desalted whey that will refuel
With feed powder, edible glucose, α-lactalbumin, depth hydrolysis' albumen, FOS, galactooligosaccharide, lactase according to formula
Each component mass percent precise feed intake successively into mixing tank in order it is abundant mix, sieve to obtain aniseed bag；
Step 4：The mineral-supplemented dose of bag and vitamin enrichment bag that step 2 is mixed put into aniseed bag and filled successively
Divide mixing, sieving produces product.
Wherein, sieving is 60 mesh sieves in the step one；Sieving is mistake in 60 mesh sieves, the step 3 in the step 2
Sieve as 40 mesh sieves.
The process of manufacture stage of icterus small peptide growing nutrient element in the present invention, it is reasonable in design, it is easy to accomplish and production,
It is easy to control product quality.
Embodiment 1：
Stage of icterus small peptide growing nutrient element, including oiling desalted whey match somebody with somebody feed powder, edible glucose, α-lactalbumin, depth
Protein hydrolysate, nutrition fortifier, FOS, galactooligosaccharide, lactase, algae oil DHA powder, ARA powder are spent, each component accounts for product
Mass percent：Oiling desalted whey matches somebody with somebody feed powder 59.85-87.27%%, depth hydrolysis albumen 1.40%-7.30%, α-breast
Albumin 1.00%-5.70%, edible glucose 6.15%-18.37%, nutrition fortifier 1.07%-2.60%, FOS
1.58%-2.63%, galactooligosaccharide 1.30%-2.20%, lactase 0.05%-0.25%, algae oil DHA powder 0.08%-
0.40%, ARA powder 0.10%-0.70%, wherein oiling desalted whey, which match somebody with somebody, includes medium chain fatty acid MCT, oiling desalination in feed powder
The medium chain fatty acid MCT that whey is matched somebody with somebody in feed powder accounts for the 23.94%-34.91% of this product；Nutrition fortifier includes calcium carbonate, phosphorus
Sour DFP, ferric pyrophosphate, zinc gluconate, vitamin A, vitamin D3, vitamin E, vitamin B1, vitamin B2, vitamin
B6, vitamin B12, nicotinic acid, folic acid, D-VB5 calcium, vitamin C.Each component nutrient accounts for the quality percentage of total nutrition fortifier
Than：Calcium carbonate 15.96%-21.04%, tricalcium phosphate 51.09%-29.95%, ferric pyrophosphate 9.85%-13.76%, grape
Saccharic acid zinc 2.23%-6.79%, vitamin A 0.31%-0.71%, vitamin D30.05%-0.09%, vitamin E
2.34%-2.77%, vitamin B10.07%-0.47%, vitamin B21.34%-1.81%, vitamin B60.04%-
0.44%th, vitamin B120.07%-0.47%, nicotinic acid 1.49%-1.91%, folic acid 0.06%-0.11%, D-VB5 calcium
0.18%-0.58%, vitamin C 14.92%-19.10%.
Each component is acted on：Oiling desalted whey mainly provides the fat and protein of product with feed powder.Desalted whey powder is
Mineral salt in whey powder is sloughed.For infant, content of mineral substances is too high to increase the kidney burden of baby, therefore breast
Clear powder typically can all slough mineral matter.It is to increase grease on this basis to meet infant to fat that oiling desalted whey, which matches somebody with somebody feed powder,
The requirement of fat.
α-lactalbumin can be coupled with unconjugated bilirubin, so as to prevent bilirubin from passing through pellicle such as cell membrane, tire
Disk, gall-bladder, blood-brain barrier；
Edible monomeric glucose can change into glucuronic acid in vivo, and glucuronic acid is in glucuronyl transferase
It can be combined to form under catalytic action with unconjugated bilirubin with reference to bilirubin so as to discharge it in vitro, to promoting icterus neonatorum
Treatment have very great help；
Depth hydrolysis' albumen reduces the possibility of neonate's milk protein allergy, and lactase can prevent premature or new life again
Youngster's lactose intolerance, helps baby in stage of icterus, while alleviating and shorten the jaundice course of disease, evades milk protein allergy and breast
Sugar can ensure that body obtains the sufficient nutrition for meeting demand of growing again intolerant to problem.
Compound nutrition fortifier, it is therefore intended that improve food nutrition density, make up the mesotrophic loss of Dairy Processing, more
Close to breast milk composition, the nutritional need of infant's normal growth is met.In addition, can especially be supplemented using food enrichment
Some nutriments, reach the purpose of special diet and health.Nutrition fortifier not only improves the nutritional quality of food, can be with
Reduce and prevent many deficiency diseases and other caused complication of nutritional deficiency, some nutrition fortifiers also have raising food concurrently
The aesthetic quality of product and the effect of keeping property.
FOS, galactooligosaccharide, lactase, algae oil DHA powder, ARA powder are association area usual ingredients, are act as often
See function.
A kind of process for manufacturing stage of icterus small peptide growing nutrient element, it is characterised in that comprise the following steps：
Step one：Determine to need the nutrition fortifier pre-processed in advance to have tricalcium phosphate, calcium carbonate, vitamin C, Jiao first
Ferric phosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, vitamin B2, vitamin B6, dimension
Raw element D3, folic acid, vitamin B12, processing method is as follows：
(1) vitamin B2, folic acid, vitamin B12Gradient dilution is needed to handle, according to the dilution ratio of different material, accurately
Calculate raw material and oiling desalted whey matches somebody with somebody the consumption of feed powder, carry out respectively after gradient mixing, sieve 60 mesh sieves respectively, then enters respectively
Mixing tank is well mixed, and tank is gone out respectively and crosses 60 mesh sieves, standard compliant raw material after being handled, specific raw material dilution ratio is shown in
Table：
| Material name | Before processing content of monomer | Add auxiliary material | Content of monomer after processing |
| Vitamin B2 | 100% | Oiling desalted whey matches somebody with somebody feed powder | 10% |
| Vitamin B12 | 98% | Oiling desalted whey matches somebody with somebody feed powder | 0.1% |
| Folic acid | 98% | Oiling desalted whey matches somebody with somebody feed powder | 10% |
(2) tricalcium phosphate, calcium carbonate, vitamin C, ferric pyrophosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A,
D-VB5 calcium, vitamin B1, vitamin B6, vitamin D3Need to cross 60 mesh sieves respectively, take respective screenings, then will each sieve
Upper thing crosses 60 mesh sieves respectively by crushing, grinding again, obtains the standard compliant raw material of institute, and specifically used equipment refers to Tianjin moral
The patent application of permanent Science and Technology Ltd.：The entitled rotary sealing device of rotating shaft of Application No. 200920096540.9, application
Number device is pulverized and mixed for 200920096539.6 entitled one kind.
Step 2：Hardening agent component is supported into according to prescription quality percentage precise by each processing rear batallion, specifically：
Each component nutrient accounts for the mass percent of total nutrition fortifier in formula：Calcium carbonate 15.96%-21.04%,
Tricalcium phosphate 29.95%-51.09%, ferric pyrophosphate 9.85%-13.76%, zinc gluconate 2.23%-6.79%, vitamin
A0.31%-0.71%, vitamin D30.05%-0.09%, vitamin E 2.34%-2.77%, vitamin B10.07%-
0.47%th, vitamin B21.34%-1.81%, vitamin B60.04%-0.44%, vitamin B120.07%-0.47%,
Nicotinic acid 1.49%-1.91%, folic acid 0.06%-0.11%, D-VB5 calcium 0.18%-0.58%, vitamin C 14.92%-
19.10%；
1) tricalcium phosphate, calcium carbonate, ferric pyrophosphate, zinc gluconate are added into mixing tank successively in order first to be filled
Divide and mixed 60 mesh sieves, obtain mineral-supplemented dose of bag；
2) and then in order successively by vitamin C, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, dimension life
Plain B2, vitamin B6, vitamin D3, folic acid, vitamin B12Add mixing tank to carry out being sufficiently mixed 60 mesh sieves, obtain vitamin
Hardening agent bag；
Step 3：According to each component mass percent precise is formulated, specifically：
Each component accounts for the mass percent of product：Oiling desalted whey matches somebody with somebody feed powder 59.85%-87.27%, depth hydrolysis' egg
White 1.40%-7.30%, α-lactalbumin 1.00%-5.70%, edible glucose 6.15%-18.37%, nutrition fortifier
1.07%-2.60%, FOS 1.58%-2.63%, galactooligosaccharide 1.30%-2.20%, lactase 0.05%-
0.25%, algae oil DHA powder 0.08%-0.40%, ARA powder 0.10%-0.70%；
Except nutrition fortifier weighs mixing in step 2, other components process step is as follows：And the desalted whey that will refuel
With feed powder, edible glucose, α-lactalbumin, depth hydrolysis' albumen, FOS, galactooligosaccharide, lactase according to formula
Each component mass percent precise feed intake successively into mixing tank in order it is abundant mix, obtain aniseed bag；
Step 4：The mineral-supplemented dose of bag and vitamin enrichment bag that step 2 is mixed put into aniseed bag and filled successively
Divide mixing, cross 40 mesh sieves and produce product.
The process of manufacture stage of icterus small peptide growing nutrient element in the present invention, it is reasonable in design, it is easy to accomplish and production,
It is easy to control product quality.
Embodiment 2：
Stage of icterus small peptide growing nutrient element, including oiling desalted whey match somebody with somebody feed powder, edible glucose, α-lactalbumin, depth
Protein hydrolysate, nutrition fortifier, FOS, galactooligosaccharide, lactase, algae oil DHA powder, ARA powder are spent, each component accounts for product
Mass percent：Oiling desalted whey matches somebody with somebody feed powder 78.92%, depth hydrolysis' albumen 3.14%, α-lactalbumin 4.79%, food
With glucose 6.89%, nutrition fortifier 1.17%, FOS 2.53%, galactooligosaccharide 2.11%, lactase 0.15%,
Algae oil DHA powder 0.10%, ARA powder 0.20%, wherein oiling desalted whey, which are matched somebody with somebody, includes medium chain fatty acid MCT in feed powder, refuel de-
The medium chain fatty acid MCT that salt whey is matched somebody with somebody in feed powder accounts for the 31.57% of product；Nutrition fortifier includes calcium carbonate, tricalcium phosphate, Jiao
Ferric phosphate, zinc gluconate, vitamin A, vitamin D3, vitamin E, vitamin B1, vitamin B2, vitamin B6, vitamin
B12, nicotinic acid, folic acid, D-VB5 calcium, vitamin C.Each component nutrient accounts for the mass percent of total nutrition fortifier：Calcium carbonate
17.96%th, tricalcium phosphate 39.73%, ferric pyrophosphate 12.99%, zinc gluconate 4.79%, vitamin A 0.51%, dimension life
Plain D30.07%th, vitamin E 2.57%, vitamin B10.17%th, vitamin B21.58%th, vitamin B60.15%th, tie up
Raw element B120.17%th, nicotinic acid 1.71%, folic acid 0.09%, D-VB5 calcium 0.38%, vitamin C 17.13%.
Each component is acted on：Oiling desalted whey mainly provides the fat and protein of product with feed powder.Desalted whey powder is
Mineral salt in whey powder is sloughed.For infant, content of mineral substances is too high to increase the kidney burden of baby, therefore breast
Clear powder typically can all slough mineral matter.It is to increase grease on this basis to meet infant to fat that oiling desalted whey, which matches somebody with somebody feed powder,
The requirement of fat.
α-lactalbumin can be coupled with unconjugated bilirubin, so as to prevent bilirubin from passing through pellicle such as cell membrane, tire
Disk, gall-bladder, blood-brain barrier；
Edible monomeric glucose can change into glucuronic acid in vivo, and glucuronic acid is in glucuronyl transferase
It can be combined to form under catalytic action with unconjugated bilirubin with reference to bilirubin so as to discharge it in vitro, to promoting icterus neonatorum
Treatment have very great help；
Depth hydrolysis' albumen reduces the possibility of neonate's milk protein allergy, and lactase can prevent premature or new life again
Youngster's lactose intolerance, helps baby in stage of icterus, while alleviating and shorten the jaundice course of disease, evades milk protein allergy and breast
Sugar can ensure that body obtains the sufficient nutrition for meeting demand of growing again intolerant to problem.
Nutrition fortifier is using compounding nutrition fortifier, it is therefore intended that improves food nutrition density, makes up in Dairy Processing
The loss of nutrition, is more nearly breast milk composition, meets the nutritional need of infant's normal growth.In addition, strong using food nutrition
Agent can especially supplement some nutriments, reach the purpose of special diet and health.Nutrition fortifier not only improves food
Nutritional quality, can also reduce and prevent many deficiency diseases and nutritional deficiency caused by other complication, some nutrition
Hardening agent also has the effect of the aesthetic quality for improving food and keeping property concurrently.
FOS, galactooligosaccharide, lactase, algae oil DHA powder, ARA powder are association area usual ingredients, are act as often
See function.
A kind of process for manufacturing stage of icterus small peptide growing nutrient element, it is characterised in that comprise the following steps：
Step one：Determine to need the nutrition fortifier pre-processed in advance to have tricalcium phosphate, calcium carbonate, vitamin C, Jiao first
Ferric phosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, vitamin B2, vitamin B6, dimension
Raw element D3, folic acid, vitamin B12, processing method is as follows：
(1) vitamin B2, folic acid, vitamin B12Gradient dilution is needed to handle, according to the dilution ratio of different material, accurately
Calculate raw material and oiling desalted whey matches somebody with somebody the consumption of feed powder, carry out respectively after gradient mixing, sieve 60 mesh sieves respectively, then enters respectively
Mixing tank is well mixed, and tank is gone out respectively and crosses 60 mesh sieves, standard compliant raw material after being handled, specific raw material dilution ratio is shown in
Table：
| Material name | Before processing content of monomer | Add auxiliary material | Content of monomer after processing |
| Vitamin B2 | 100% | Oiling desalted whey matches somebody with somebody feed powder | 10% |
| Vitamin B12 | 98% | Oiling desalted whey matches somebody with somebody feed powder | 0.1% |
| Folic acid | 98% | Oiling desalted whey matches somebody with somebody feed powder | 10% |
(2) tricalcium phosphate, calcium carbonate, vitamin C, ferric pyrophosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A,
D-VB5 calcium, vitamin B1, vitamin B6, vitamin D3Need to cross 60 mesh sieves respectively, take respective screenings, then will each sieve
Upper thing again by crushing, it is ground cross 60 mesh sieves respectively, obtain the standard compliant raw material of institute, specifically used equipment refers to Tianjin
The patent application of De Heng Science and Technology Ltd.s：The entitled rotary sealing device of rotating shaft of Application No. 200920096540.9, Shen
Number device please be pulverized and mixed for 200920096539.6 entitled one kind.
Step 2：Hardening agent component is supported into according to prescription quality percentage precise by each processing rear batallion, specifically：
Each component nutrient accounts for the mass percent of total nutrition fortifier in formula：Calcium carbonate 17.96%, tricalcium phosphate
39.73%th, ferric pyrophosphate 12.99%, zinc gluconate 4.79%, vitamin A 0.51%, vitamin D30.07%th, dimension life
Plain E 2.57%, vitamin B10.17%th, vitamin B21.58%th, vitamin B60.15%th, vitamin B120.17%th, nicotinic acid
1.71%th, folic acid 0.09%, D-VB5 calcium 0.38%, vitamin C 17.13%, processing method is such as
1) tricalcium phosphate, calcium carbonate, ferric pyrophosphate, zinc gluconate are added into mixing tank successively in order first to be filled
Divide and mixed 60 mesh sieves, obtain mineral-supplemented dose of bag；
2) and then in order successively by vitamin C, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, dimension life
Plain B2, vitamin B6, vitamin D3, folic acid, vitamin B12Add mixing tank to carry out being sufficiently mixed 60 mesh sieves, obtain vitamin
Hardening agent bag；
Step 3：According to each component mass percent precise is formulated, specifically：
Each component accounts for the mass percent of product：Oiling desalted whey matches somebody with somebody feed powder 78.92%, depth hydrolysis' albumen
3.14%, α-lactalbumin 4.79%, edible glucose 6.89%, nutrition fortifier 1.17%, FOS 2.53% is oligomeric
Galactolipin 2.11%, lactase 0.15%, algae oil DHA powder 0.10%, wherein ARA powder 0.20%, oiling desalted whey match somebody with somebody feed powder
In include medium chain fatty acid MCT, oiling desalted whey match somebody with somebody feed powder in medium chain fatty acid MCT account for the 31.57% of this product；
It is mixed into except nutrition fortifier is weighed in step 2, other components process step is as follows：And oiling desalination is newborn
Clearly with feed powder, edible glucose, α-lactalbumin, depth hydrolysis' albumen, FOS, galactooligosaccharide, lactase according to matching somebody with somebody
Square each component mass percent precise feed intake successively into mixing tank in order it is abundant mix, obtain aniseed bag；
Step 4：The mineral-supplemented dose of bag and vitamin enrichment bag that step 2 is mixed put into aniseed bag and filled successively
Divide mixing, cross 40 mesh sieves and produce product.
The process of manufacture stage of icterus small peptide growing nutrient element in the present invention, it is reasonable in design, it is easy to accomplish and production,
It is easy to control product quality.
Embodiment 3：
Stage of icterus small peptide growing nutrient element, including oiling desalted whey match somebody with somebody feed powder, edible glucose, α-lactalbumin, depth
Protein hydrolysate, nutrition fortifier, FOS, galactooligosaccharide, lactase, algae oil DHA powder, ARA powder are spent, each component accounts for product
Mass percent：Oiling desalted whey matches somebody with somebody feed powder 64.49%, depth hydrolysis' albumen 6.32%, α-lactalbumin 5.45%, food
With glucose 18.37%, nutrition fortifier 1.18%, FOS 1.71%, galactooligosaccharide 1.43%, lactase
0.15%, algae oil DHA powder 0.30%, ARA powder 0.60%, wherein oiling desalted whey, which are matched somebody with somebody, includes medium chain fatty acid MCT in feed powder,
The medium chain fatty acid MCT that oiling desalted whey is matched somebody with somebody in feed powder accounts for the 25.80% of product；Nutrition fortifier includes calcium carbonate, phosphoric acid
DFP, ferric pyrophosphate, zinc gluconate, vitamin A, vitamin D3, vitamin E, vitamin B1, vitamin B2, vitamin B6、
Vitamin B12, nicotinic acid, folic acid, D-VB5 calcium, vitamin C.Each component nutrient accounts for the mass percent of total nutrition fortifier：
Calcium carbonate 16.04%, tricalcium phosphate 43.53%, ferric pyrophosphate 11.89%, zinc gluconate 4.23%, vitamin A
0.51%th, vitamin D30.07%th, vitamin E 2.56%, vitamin B10.17%th, vitamin B21.61%th, vitamin B6
0.15%th, vitamin B120.17%th, nicotinic acid 1.69%, folic acid 0.08%, D-VB5 calcium 0.38%, vitamin C 16.92%.
Each component is acted on：Oiling desalted whey mainly provides the fat and protein of product with feed powder.Desalted whey powder is
Mineral salt in whey powder is sloughed.For infant, content of mineral substances is too high to increase the kidney burden of baby, therefore breast
Clear powder typically can all slough mineral matter.It is to increase grease on this basis to meet infant to fat that oiling desalted whey, which matches somebody with somebody feed powder,
The requirement of fat.
α-lactalbumin can be coupled with unconjugated bilirubin, so as to prevent bilirubin from passing through pellicle such as cell membrane, tire
Disk, gall-bladder, blood-brain barrier；
Edible monomeric glucose can change into glucuronic acid in vivo, and glucuronic acid is in glucuronyl transferase
It can be combined to form under catalytic action with unconjugated bilirubin with reference to bilirubin so as to discharge it in vitro, to promoting icterus neonatorum
Treatment have very great help；
Depth hydrolysis' albumen reduces the possibility of neonate's milk protein allergy, and lactase can prevent premature or new life again
Youngster's lactose intolerance, helps baby in stage of icterus, while alleviating and shorten the jaundice course of disease, evades milk protein allergy and breast
Sugar can ensure that body obtains the sufficient nutrition for meeting demand of growing again intolerant to problem.
Nutrition fortifier is using compounding nutrition fortifier, it is therefore intended that improves food nutrition density, makes up in Dairy Processing
The loss of nutrition, is more nearly breast milk composition, meets the nutritional need of infant's normal growth.In addition, strong using food nutrition
Agent can especially supplement some nutriments, reach the purpose of special diet and health.Nutrition fortifier not only improves food
Nutritional quality, can also reduce and prevent many deficiency diseases and nutritional deficiency caused by other complication, some nutrition
Hardening agent also has the effect of the aesthetic quality for improving food and keeping property concurrently.
FOS, galactooligosaccharide, lactase, algae oil DHA powder, ARA powder are association area usual ingredients, are act as often
See function.
A kind of process for manufacturing stage of icterus small peptide growing nutrient element, it is characterised in that comprise the following steps：
Step one：Determine to need the nutrition fortifier pre-processed in advance to have tricalcium phosphate, calcium carbonate, vitamin C, Jiao first
Ferric phosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, vitamin B2, vitamin B6, dimension
Raw element D3, folic acid, vitamin B12, processing method is as follows：
(1) vitamin B2, folic acid, vitamin B12Gradient dilution is needed to handle, according to the dilution ratio of different material, accurately
Calculate raw material and oiling desalted whey matches somebody with somebody the consumption of feed powder, carry out respectively after gradient mixing, sieve 60 mesh sieves respectively, then enters respectively
Mixing tank is well mixed, and tank is gone out respectively and crosses 60 mesh sieves, standard compliant raw material after being handled, specific raw material dilution ratio is shown in
Table：
| Material name | Before processing content of monomer | Add auxiliary material | Content of monomer after processing |
| Vitamin B2 | 100% | Oiling desalted whey matches somebody with somebody feed powder | 10% |
| Vitamin B12 | 98% | Oiling desalted whey matches somebody with somebody feed powder | 0.1% |
| Folic acid | 98% | Oiling desalted whey matches somebody with somebody feed powder | 10% |
(2) tricalcium phosphate, calcium carbonate, vitamin C, ferric pyrophosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A,
D-VB5 calcium, vitamin B1, vitamin B6, vitamin D3Need to cross 60 mesh sieves respectively, take respective screenings, then will each sieve
Upper thing again by crushing, it is ground cross 60 mesh sieves respectively, obtain the standard compliant raw material of institute, specifically used equipment refers to Tianjin
The patent application of De Heng Science and Technology Ltd.s：The entitled rotary sealing device of rotating shaft of Application No. 200920096540.9, Shen
Number device please be pulverized and mixed for 200920096539.6 entitled one kind.
Step 2：Hardening agent component is supported into according to prescription quality percentage precise by each processing rear batallion, specifically：
Each component nutrient accounts for the mass percent of total nutrition fortifier in formula：Calcium carbonate 16.04%, tricalcium phosphate
43.53%th, ferric pyrophosphate 11.89%, zinc gluconate 4.23%, vitamin A 0.51%, vitamin D30.07%th, dimension life
Plain E2.56%, vitamin B10.17%th, vitamin B21.61%th, vitamin B60.15%th, vitamin B120.17%th, nicotinic acid
1.69%th, folic acid 0.08%, D-VB5 calcium 0.38%, vitamin C 16.92%；
1) tricalcium phosphate, calcium carbonate, ferric pyrophosphate, zinc gluconate are added into mixing tank successively in order first to be filled
Divide and mixed 60 mesh sieves, obtain mineral-supplemented dose of bag；
2) and then in order successively by vitamin C, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, dimension life
Plain B2, vitamin B6, vitamin D3, folic acid, vitamin B12Add mixing tank to carry out being sufficiently mixed 60 mesh sieves, obtain vitamin
Hardening agent bag；
Step 3：According to each component mass percent precise is formulated, specifically：
Each component accounts for the mass percent of product：Oiling desalted whey matches somebody with somebody feed powder 64.49%, depth hydrolysis' albumen
6.32%, α-lactalbumin 5.45%, edible glucose 18.37%, nutrition fortifier 1.18%, FOS 1.71% is low
Poly- galactolipin 1.43%, lactase 0.15%, algae oil DHA powder 0.30%, wherein ARA powder 0.60%, oiling desalted whey dispensing
Medium chain fatty acid MCT is included in powder, the medium chain fatty acid MCT that oiling desalted whey is matched somebody with somebody in feed powder accounts for the 25.80% of product；
It is mixed into except nutrition fortifier is weighed in step 2, other components process step is as follows：And oiling desalination is newborn
Clearly with feed powder, edible glucose, α-lactalbumin, depth hydrolysis' albumen, FOS, galactooligosaccharide, lactase according to matching somebody with somebody
Square each component mass percent precise feed intake successively into mixing tank in order it is abundant mix, obtain aniseed bag；
Step 4：The mineral-supplemented dose of bag and vitamin enrichment bag that step 2 is mixed put into aniseed bag and filled successively
Divide mixing, cross 40 mesh sieves and produce product.
The process of manufacture stage of icterus small peptide growing nutrient element in the present invention, it is reasonable in design, it is easy to accomplish and production,
It is easy to control product quality.
Embodiment 4：
Stage of icterus small peptide growing nutrient element, including oiling desalted whey match somebody with somebody feed powder, edible glucose, α-lactalbumin, depth
Protein hydrolysate, nutrition fortifier, FOS, galactooligosaccharide, lactase, algae oil DHA powder, ARA powder are spent, each component accounts for product
Mass percent：Oiling desalted whey matches somebody with somebody feed powder 72.12%, depth hydrolysis' albumen 3.06%, α-lactalbumin 4.71%, food
With glucose 15.08%, nutrition fortifier 1.17%, FOS 1.68%, galactooligosaccharide 1.43%, lactase
0.15%, algae oil DHA powder 0.20%, ARA powder 0.40%.Wherein oiling desalted whey, which is matched somebody with somebody, includes medium chain fatty acid MCT in feed powder,
The medium chain fatty acid MCT that oiling desalted whey is matched somebody with somebody in feed powder accounts for the 28.85% of product；Nutrition fortifier includes calcium carbonate, phosphoric acid
DFP, ferric pyrophosphate, zinc gluconate, vitamin A, vitamin D3, vitamin E, vitamin B1, vitamin B2, vitamin B6、
Vitamin B12, nicotinic acid, folic acid, D-VB5 calcium, vitamin C.Each component nutrient accounts for the mass percent of total nutrition fortifier：
Calcium carbonate 15.57%, tricalcium phosphate 46.95%, ferric pyrophosphate 10.75%, zinc gluconate 3.97%, vitamin A
0.51%th, vitamin D30.07%th, vitamin E 2.57%, vitamin B10.17%th, vitamin B21.54%th, vitamin B6
0.12%th, vitamin B120.17%th, nicotinic acid 1.13%, folic acid 0.09%, D-VB5 calcium 0.38%, vitamin C 16.01%.
Each component is acted on：Oiling desalted whey mainly provides the fat and protein of product with feed powder.Desalted whey powder is
Mineral salt in whey powder is sloughed.For infant, content of mineral substances is too high to increase the kidney burden of baby, therefore breast
Clear powder typically can all slough mineral matter.It is to increase grease on this basis to meet infant to fat that oiling desalted whey, which matches somebody with somebody feed powder,
The requirement of fat.
α-lactalbumin can be coupled with unconjugated bilirubin, so as to prevent bilirubin from passing through pellicle such as cell membrane, tire
Disk, gall-bladder, blood-brain barrier；
Edible monomeric glucose can change into glucuronic acid in vivo, and glucuronic acid is in glucuronyl transferase
It can be combined to form under catalytic action with unconjugated bilirubin with reference to bilirubin so as to discharge it in vitro, to promoting icterus neonatorum
Treatment have very great help.；
Depth hydrolysis' albumen reduces the possibility of neonate's milk protein allergy, and lactase can prevent premature or new life again
Youngster's lactose intolerance, helps baby in stage of icterus, while alleviating and shorten the jaundice course of disease, evades milk protein allergy and breast
Sugar can ensure that body obtains the sufficient nutrition for meeting demand of growing again intolerant to problem.
Compound nutrition fortifier, it is therefore intended that improve food nutrition density, make up the mesotrophic loss of Dairy Processing, more
Close to breast milk composition, the nutritional need of infant's normal growth is met.Nutrition fortifier not only improves the nutritional quality of food, also
It can reduce and prevent many deficiency diseases and other caused complication of nutritional deficiency, some nutrition fortifiers, which also have concurrently, to be carried
The aesthetic quality of high food and the effect of keeping property.
FOS, galactooligosaccharide, lactase, algae oil DHA powder, ARA powder are association area usual ingredients, are act as often
See function.
A kind of process for manufacturing stage of icterus small peptide growing nutrient element, it is characterised in that comprise the following steps：
Step one：Determine to need the nutrition fortifier pre-processed in advance to have tricalcium phosphate, calcium carbonate, vitamin C, Jiao first
Ferric phosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, vitamin B2, vitamin B6, dimension
Raw element D3, folic acid, vitamin B12, processing method is as follows：
(1) vitamin B2, folic acid, vitamin B12Gradient dilution is needed to handle, according to the dilution ratio of different material, accurately
Calculate raw material and oiling desalted whey matches somebody with somebody the consumption of feed powder, carry out respectively after gradient mixing, sieve 60 mesh sieves respectively, then enters respectively
Mixing tank is well mixed, and tank is gone out respectively and crosses 60 mesh sieves, standard compliant raw material after being handled, specific raw material dilution ratio is shown in
Table：
| Material name | Before processing content of monomer | Add auxiliary material | Content of monomer after processing |
| Vitamin B2 | 100% | Oiling desalted whey matches somebody with somebody feed powder | 10% |
| Vitamin B12 | 98% | Oiling desalted whey matches somebody with somebody feed powder | 0.1% |
| Folic acid | 98% | Oiling desalted whey matches somebody with somebody feed powder | 10% |
(2) tricalcium phosphate, calcium carbonate, vitamin C, ferric pyrophosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A,
D-VB5 calcium, vitamin B1, vitamin B6, vitamin D3Need to cross 60 mesh sieves respectively, take respective screenings, then will each sieve
Upper thing again by crushing, it is ground cross 60 mesh sieves respectively, obtain the standard compliant raw material of institute, specifically used equipment refers to Tianjin
The patent application of De Heng Science and Technology Ltd.s：The entitled rotary sealing device of rotating shaft of Application No. 200920096540.9, Shen
Number device please be pulverized and mixed for 200920096539.6 entitled one kind.
Step 2：Hardening agent component is supported into according to prescription quality percentage precise by each processing rear batallion, specifically：
Each component nutrient accounts for the mass percent of total nutrition fortifier in formula：Calcium carbonate 15.57%, tricalcium phosphate
46.95%th, ferric pyrophosphate 10.75%, zinc gluconate 3.97%, vitamin A 0.51%, vitamin D30.07%th, dimension life
Plain E 2.57%, vitamin B10.17%th, vitamin B21.54%th, vitamin B60.12%th, vitamin B120.17%th, cigarette
Acid 1.13%, folic acid 0.09%, D-VB5 calcium 0.38%, vitamin C 16.01%, processing method is such as
1) tricalcium phosphate, calcium carbonate, ferric pyrophosphate, zinc gluconate are added into mixing tank successively in order first to be filled
Divide and mixed 60 mesh sieves, obtain mineral-supplemented dose of bag；
2) and then in order successively by vitamin C, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, dimension life
Plain B2, vitamin B6, vitamin D3, folic acid, vitamin B12Add mixing tank to carry out being sufficiently mixed 60 mesh sieves, obtain vitamin
Hardening agent bag；
Step 3：According to each component mass percent precise is formulated, specifically：
Each component accounts for the mass percent of product：Oiling desalted whey matches somebody with somebody feed powder 72.12%, depth hydrolysis' albumen
3.06%, α-lactalbumin 4.71%, edible glucose 15.08%, nutrition fortifier 1.17%, FOS 1.68% is low
Poly- galactolipin 1.43%, lactase 0.15%, algae oil DHA powder 0.20%, ARA powder 0.40%, wherein oiling desalted whey dispensing
Medium chain fatty acid MCT is included in powder, the medium chain fatty acid MCT that oiling desalted whey is matched somebody with somebody in feed powder accounts for the 28.85% of this product；
It is mixed into except nutrition fortifier is weighed in step 2, other components process step is as follows：And oiling desalination is newborn
Clearly basis is pressed with feed powder, edible glucose, α-lactalbumin, depth hydrolysis' albumen, FOS, galactooligosaccharide, lactase
Formula each component mass percent precise order fed intake successively into mixing tank it is abundant mix, obtain aniseed bag；
Step 4：The mineral-supplemented dose of bag and vitamin enrichment bag that step 2 is mixed put into aniseed bag and filled successively
Divide mixing, cross 40 mesh sieves and produce product.
The process of manufacture stage of icterus small peptide growing nutrient element in the present invention, it is reasonable in design, it is easy to accomplish and production,
It is easy to control product quality.
Contrast groups data：
Embodiment 1,2,3,4 is 4 kinds of factory formulas citing of the stage of icterus small peptide nutrient element of the present invention, selects any, takes
With stage of icterus small peptide nutrient of the present invention element, with taking " comfortable jaundice nutrient ", and only with blue-light treatment, with using stage of icterus
Small peptide nutrient element auxiliary three kinds of contrasts of blue-light treatment, front and rear bilirubin change indicator situation (see specification P5).
By control group data, when showing to use each component mass percent in embodiment 4, the Huang of the application is used alone
Subcutaneous ulcer phase small peptide growing nutrient element, bilirubin declines obvious.Using stage of icterus small peptide nutrient element auxiliary blue-light treatment, stage of icterus small peptide
Nutrient coordinates auxiliary blue light illumination to be relieved jaundice and effectively shortens the jaundice course of disease, compared to other embodiment, embodiment 4
It is better.
An example of the present invention is described in detail above, but content is only presently preferred embodiments of the present invention, no
The practical range for limiting the present invention can be considered as.Any changes and modifications in accordance with the scope of the present application,
Within the patent covering scope that the present invention should still be belonged to.
Claims (10)
1. stage of icterus small peptide growing nutrient is plain, including oiling desalted whey matches somebody with somebody feed powder, edible glucose, α-lactalbumin, depth
Protein hydrolysate, nutrition fortifier, FOS, galactooligosaccharide, lactase, algae oil DHA powder, ARA powder.
2. stage of icterus small peptide growing nutrient element according to claim 1, it is characterised in that each component accounts for the quality hundred of product
Divide ratio：Oiling desalted whey matches somebody with somebody feed powder 59.85%-87.27%, depth hydrolysis albumen 1.40%-7.30%, α-lactalbumin
1.00%-5.70%, edible glucose 6.15%-18.37%, nutrition fortifier 1.07%-2.60%, FOS
1.58%-2.63%, galactooligosaccharide 1.30%-2.20%, lactase 0.05%-0.25%, algae oil DHA powder 0.08%-
0.40%, ARA powder 0.10%-0.70%.
3. stage of icterus small peptide growing nutrient element according to claim 2, it is characterised in that oiling desalted whey is matched somebody with somebody in feed powder
Include medium chain fatty acid MCT.
4. the stage of icterus small peptide growing nutrient element according to Claims 2 or 3, it is characterised in that nutrition fortifier includes carbonic acid
Calcium, tricalcium phosphate, ferric pyrophosphate, zinc gluconate, vitamin A, vitamin D3, vitamin E, vitamin B1, vitamin B2, dimension
Raw element B6, vitamin B12, nicotinic acid, folic acid, D-VB5 calcium, vitamin C.
5. the stage of icterus small peptide growing nutrient element according to claim 3 or 4, it is characterised in that oiling desalted whey matches somebody with somebody feed powder
In medium chain fatty acid MCT account for the 23.94%-34.91% of this product.
6. stage of icterus small peptide growing nutrient element according to claim 5, it is characterised in that each component nutrient accounts for Zong Ying
Support the mass percent of hardening agent：Calcium carbonate 15.96%-21.04%, tricalcium phosphate 29.95%-51.09%, ferric pyrophosphate
9.85%-13.76%, zinc gluconate 2.23%-6.79%, vitamin A 0.31%-0.71%, vitamin D30.05%-
0.09%th, vitamin E 2.34%-2.77%, vitamin B10.07%-0.47%, vitamin B21.34%-1.81%, dimension
Raw element B60.04%-0.44%, vitamin B120.07%-0.47%, nicotinic acid 1.49%-1.91%, folic acid 0.06%-
0.11%th, D-VB5 calcium 0.18%-0.58%, vitamin C 14.92%-19.10%.
7. a kind of process for manufacturing the stage of icterus small peptide growing nutrient element as described in claim 1-6 is any, it is characterised in that
Comprise the following steps：
Step one：Determine to need the nutrition fortifier pre-processed in advance to have tricalcium phosphate, calcium carbonate, vitamin C, pyrophosphoric acid first
Iron, zinc gluconate, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, vitamin B2, vitamin B6, vitamin
D3, folic acid, vitamin B12, processing method is as follows：
(1) vitamin B2, folic acid, vitamin B12Gradient dilution is needed to handle, it is accurate to calculate according to the dilution ratio of different material
Raw material and oiling desalted whey match somebody with somebody the consumption of feed powder, carry out after gradient mixing, sieve respectively respectively, then enter mixing tank mixing respectively
Uniformly, tank sieving, standard compliant raw material after being handled are gone out respectively；
(2) tricalcium phosphate, calcium carbonate, vitamin C, ferric pyrophosphate, zinc gluconate, vitamin E, nicotinic acid, vitamin A, D- are general
Sour calcium, vitamin B1, vitamin B6, vitamin D3Need first to sieve, extracting screen underflow, then oversize again through crushing, it is ground
Sieve, obtains the standard compliant raw material of institute.
Step 2：Hardening agent component is supported into according to prescription quality percentage precise by each processing rear batallion, specifically：
1) tricalcium phosphate, calcium carbonate, ferric pyrophosphate, zinc gluconate are added into mixing tank successively in order first fully mix
Sieving is closed, mineral-supplemented dose of bag is obtained；
2) and then in order successively by vitamin C, vitamin E, nicotinic acid, vitamin A, D-VB5 calcium, vitamin B1, vitamin B2、
Vitamin B6, vitamin D3, folic acid, vitamin B12Add mixing tank to carry out being sufficiently mixed sieving, obtain vitamin enrichment agent bag；
Step 3：According to formula each component mass percent precise and by oiling desalted whey with feed powder, edible glucose,
α-lactalbumin, depth hydrolysis' albumen, FOS, galactooligosaccharide, lactase feed intake into mixing tank fill in order successively
Divide and mix, sieve to obtain aniseed bag；
Step 4：The mineral-supplemented dose of bag and vitamin enrichment bag that step 2 is mixed are put into aniseed bag successively fully to be mixed
Close, sieving produces product.
8. a kind of process for manufacturing stage of icterus small peptide growing nutrient element according to claim 7, it is characterised in that institute
State vitamin B in step one2, folic acid, vitamin B12Gradient dilution processing is needed to specifically refer to：
Vitamin B2Before processing content of monomer 100%, adds auxiliary material oiling desalted whey and matches somebody with somebody feed powder content of monomer 10%；
Folic acid before processing content of monomer 98%, adds auxiliary material oiling desalted whey and matches somebody with somebody feed powder content of monomer 0.1%；
Vitamin B12, before processing content of monomer 98%, addition auxiliary material oiling desalted whey is with feed powder content of monomer 10%.
9. a kind of process of manufacture stage of icterus small peptide growing nutrient element according to claim 7 or 8, it is characterised in that
Sieving is 60 mesh sieves in the step one；Sieving is 60 mesh sieves in the step 2.
10. a kind of process of manufacture stage of icterus small peptide growing nutrient element according to claim 7 or 8, its feature exists
Sieving is 40 mesh sieves in the step 3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710414990.7A CN107198078A (en) | 2017-06-05 | 2017-06-05 | Stage of icterus small peptide growing nutrient element and technique manufacturing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710414990.7A CN107198078A (en) | 2017-06-05 | 2017-06-05 | Stage of icterus small peptide growing nutrient element and technique manufacturing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107198078A true CN107198078A (en) | 2017-09-26 |
Family
ID=59908374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710414990.7A Pending CN107198078A (en) | 2017-06-05 | 2017-06-05 | Stage of icterus small peptide growing nutrient element and technique manufacturing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107198078A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107712874A (en) * | 2017-10-17 | 2018-02-23 | 天津市德恒科技有限公司 | Depth hydrolysis' protein prescription powder and technique manufacturing method |
| CN110037114A (en) * | 2019-05-14 | 2019-07-23 | 宁波特壹食品有限公司 | A kind of depth hydrolysis' protein prescription powder and preparation method thereof |
| CN110037115A (en) * | 2019-05-14 | 2019-07-23 | 宁波特壹食品有限公司 | A kind of partially hydrolysed protein formula powder and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1429113A (en) * | 2000-05-08 | 2003-07-09 | 努特里奇亚有限公司 | Nutritional preparation comprising ribose and folic acid and medical use thereof |
| US20050256031A1 (en) * | 1999-01-20 | 2005-11-17 | Hageman Robert Johan J | Composition for relieving discomfort |
| CN104585327A (en) * | 2015-01-16 | 2015-05-06 | 陕西欢恩宝乳业股份有限公司 | Infant formula goat milk powder and production method thereof |
| CN104982533A (en) * | 2015-07-17 | 2015-10-21 | 多加多乳业(天津)有限公司 | Formula milk powder for enhancing immunity of infants and preparation method |
| CN106668040A (en) * | 2015-11-06 | 2017-05-17 | 合肥华方医药科技有限公司 | Medicinal composition for preventing and treating neonatal jaundice and preparation method and application thereof |
-
2017
- 2017-06-05 CN CN201710414990.7A patent/CN107198078A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050256031A1 (en) * | 1999-01-20 | 2005-11-17 | Hageman Robert Johan J | Composition for relieving discomfort |
| CN1429113A (en) * | 2000-05-08 | 2003-07-09 | 努特里奇亚有限公司 | Nutritional preparation comprising ribose and folic acid and medical use thereof |
| CN104585327A (en) * | 2015-01-16 | 2015-05-06 | 陕西欢恩宝乳业股份有限公司 | Infant formula goat milk powder and production method thereof |
| CN104982533A (en) * | 2015-07-17 | 2015-10-21 | 多加多乳业(天津)有限公司 | Formula milk powder for enhancing immunity of infants and preparation method |
| CN106668040A (en) * | 2015-11-06 | 2017-05-17 | 合肥华方医药科技有限公司 | Medicinal composition for preventing and treating neonatal jaundice and preparation method and application thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107712874A (en) * | 2017-10-17 | 2018-02-23 | 天津市德恒科技有限公司 | Depth hydrolysis' protein prescription powder and technique manufacturing method |
| CN110037114A (en) * | 2019-05-14 | 2019-07-23 | 宁波特壹食品有限公司 | A kind of depth hydrolysis' protein prescription powder and preparation method thereof |
| CN110037115A (en) * | 2019-05-14 | 2019-07-23 | 宁波特壹食品有限公司 | A kind of partially hydrolysed protein formula powder and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20190335796A1 (en) | Optimized nutrient food | |
| CN101095433A (en) | Liquid milk suitable for 1 to 3 years old children and the method for producing the same | |
| CN102550677B (en) | Liquid dairy product with health-care function on middle and old-aged people and production method for liquid dairy product | |
| CN108651988A (en) | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof | |
| CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
| CN101415429B (en) | Lipopexia inhibitor | |
| CN107712874A (en) | Depth hydrolysis' protein prescription powder and technique manufacturing method | |
| CN104605025A (en) | Pecan-milk compound protein beverage and processing method thereof | |
| CN110214941A (en) | A kind of full nutrition special medicine purposes formula nutritional powder of adult and preparation method thereof | |
| CN107198078A (en) | Stage of icterus small peptide growing nutrient element and technique manufacturing method | |
| CN106804730A (en) | The formula milk that the suitable standby pregnant phase treated constipation, period of pregnancy women eat can be prevented | |
| CN105212220A (en) | A kind of composite nutrition powder and preparation method thereof | |
| CN102048225B (en) | Red-date health protection beverage capable of improving growing development | |
| CN102318821B (en) | Special meal nutritional food applicable to males preparing childbearing | |
| CN107535605A (en) | A kind of middle-and-old-aged milk and preparation method thereof | |
| CN106578139A (en) | Rapeseed oil for invigorating brain and application of rapeseed oil | |
| CN101700074A (en) | Formula bovine colostrum | |
| CN101971942B (en) | Nitrogen source reinforced oral liquid containing peptide and oligosaccharide and preparation method thereof | |
| CN105273957A (en) | Black tartary buckwheat-all penis kidney-nourishing wine and preparation method thereof | |
| CN108157701A (en) | A kind of sea-buckthorn date-wolfberry fruit beverage and preparation method thereof | |
| CN107136490A (en) | A kind of peptide Chinese caterpillar fungus health product | |
| Fauzia et al. | The Effect of Giving Fe Tablet and Ambon Banana on Increasing Hemoglobin Levels of Third Trimester Pregnancy Woman with Anemia | |
| CN1830322A (en) | Sea cucumber milk product and its preparation method | |
| CN109567180A (en) | It is a kind of to can be used for women warp, pregnant, production, the nutriment of newborn phase and preparation method thereof | |
| CN1539304A (en) | Milk for lowering sugar and producing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170926 |